![Colin Hislop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colin Hislop
Directeur Technique/Scientifique/R&D chez
EIGER BIOPHARMACEUTICALS
Profil
Colin Hislop is currently the Senior VP-Clinical & Development Operations at Eiger BioPharmaceuticals, Inc. He previously worked as a Principal at Eli Lilly & Co. and as a Manager-Clinical Development at Procter & Gamble Co. He also held Vice President-Clinical Development positions at CV Therapeutics, Inc. and Peninsula Pharmaceuticals, Inc. from 2001 to 2005.
From 2005 to 2016, he served as the Chief Medical Officer & Senior Vice President at Anthera Pharmaceuticals, Inc. He was also the Chief Development Officer at Versartis, Inc. in 2017.
Dr. Hislop holds a doctorate from the University of London and an undergraduate degree from the University of Surrey.
Postes actifs de Colin Hislop
| Sociétés | Poste | Début |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Colin Hislop
| Sociétés | Poste | Fin |
|---|---|---|
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Directeur Technique/Scientifique/R&D | 05/09/2017 |
| ANTHERA PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/04/2016 |
Peninsula Pharmaceuticals, Inc.
 Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Directeur Technique/Scientifique/R&D | 01/06/2005 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Directeur Technique/Scientifique/R&D | 01/09/2004 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formation de Colin Hislop
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Procter & Gamble Co.
 Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Peninsula Pharmaceuticals, Inc.
Peninsula Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes antibiotics to treat life-threatening infections | Commercial Services |
Anthera Pharmaceuticals, Inc.
 Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Surrey
 University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic proteins for the treatment of metabolic diseases and endocrine disorders | Health Technology |
Eiger BioPharmaceuticals, Inc.
 Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
